Abstract
Vasoconstriction increases nnpedance to ventricular ejection and impairs the performance of the dilated myopathic heart. Vasodilator drug therapy by reducing vascular resstance, increasng vascular compliance and increasing vascular capacitance improves cardiac function and relieves the signs and symptoms of congestive heart failure. Earlier intervention in an attempt to alter the natural history of cardiomyopathy should be studied.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 599-600 |
| Number of pages | 2 |
| Journal | Postgraduate Medical Journal |
| Volume | 62 |
| Issue number | 728 |
| DOIs | |
| State | Published - 1986 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Vasodilator therapy of dilated cardiomyopathy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS